ARS Pharmaceuticals（SPRY.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

股东类型

机构投资者52.47%
风投/私募17.70%
对冲基金14.83%
私营企业9.34%
个人与内部人士5.65%

主要股东

主要股东最新
股东
RA Capital Management, L.P.	10.92%	1,086.10 万	0.02%	+0	2026/06/30
The Lowenthal-Tanimoto Family Trust	10.16%	1,010.66 万	0.02%	+0	2026/03/31
Rubric Capital Management LP	8.59%	854.09 万	0.53%	+54.09 万	2026/06/30
OrbiMed Advisors LLC	8.33%	828.85 万	0.01%	+0	2026/06/30
Deerfield Management Company, L.P.	7.55%	750.38 万	0.01%	+0	2026/06/30
BlackRock, Inc.	5.34%	531.13 万	0.29%	+29.91 万	2026/06/30
Pratik ShahChairman of the Board	4.50%	447.46 万	<0.01%	+0	2026/03/31
Tyro Capital Management, LLC	4.48%	445.93 万	1.49%	+149.07 万	2026/06/30
Aberdeen Group Plc	4.19%	417.06 万	0.05%	+5.70 万	2026/06/30
SR One Capital Management, LP	4.04%	401.29 万	<0.01%	+0	2026/06/30
State Street Investment Management	3.75%	373.06 万	0.08%	+8.57 万	2026/06/30
Vanguard Capital Management, LLC	3.03%	301.45 万	0.02%	+2.57 万	2026/06/30
Capital Research and Management Company	2.77%	275.49 万	--	+275.49 万	2026/06/30
UBS Asset Management AG	2.41%	240.10 万	0.33%	-32.40 万	2026/06/30
Millennium Management LLC	2.41%	240.09 万	3.61%	-358.20 万	2026/06/30
Janney Montgomery Scott LLC	2.08%	206.45 万	0.05%	+4.80 万	2026/06/30
Geode Capital Management, LLC	1.71%	169.90 万	0.17%	+17.22 万	2026/06/30
Boothbay Fund Management, LLC	1.61%	160.15 万	1.36%	+135.09 万	2026/06/30
Richard LowenthalCo-Founder, Former CEO & Director	1.20%	119.65 万	<0.01%	+0	2026/03/31
General American Investors Company, Inc.	1.14%	113.30 万	0.41%	+40.59 万	2026/06/30